Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-076817
Filing Date
2023-03-22
Accepted
2023-03-22 17:18:33
Documents
6
Effectiveness Date
2023-03-22

Document Format Files

Seq Description Document Type Size
1 S-8 d459189ds8.htm S-8 59191
2 EX-5.1 d459189dex51.htm EX-5.1 12380
3 EX-23.1 d459189dex231.htm EX-23.1 1635
4 EX-FILING FEES d459189dexfilingfees.htm EX-FILING FEES 15925
5 GRAPHIC g459189g0320203033620.jpg GRAPHIC 2373
6 GRAPHIC g459189g0320203033715.jpg GRAPHIC 1728
  Complete submission text file 0001193125-23-076817.txt   96118
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270758 | Film No.: 23753733
SIC: 2834 Pharmaceutical Preparations